文献速递腹部技术与安全MR

食物类对比剂在MRCP及消化道MRI中的增强效果系统综述与Meta分析

Contrast enhancement potential of food-based imaging agents in cholangiopancreatography and digestive tract investigations using MRI: A systematic literature review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2026-01-03

本研究系统回顾16项研究、共1360名受试者,评估食物类物质在MR胰胆管成像和消化道MRI中的对比增强作用。结果显示菠萝汁可改善MRCP胰胆管可见度,但在MRE中不如合成对比剂。证据总体确定性为中等。

要点

  • 菠萝汁口服后MRCP胰胆管可见度优于平扫,可作阴性对比剂备选。
  • 食物类对比剂在MRE中优质图像获得率低于合成对比剂,阅片时需注意图像质量差异。
  • 食物类对比剂安全性和接受度总体较高,但用前需考虑证据仅为中等确定性。

核心结论

  • 口服菠萝汁可提升MRCP诊断质量,而食物类物质在MRE中的对比增强效果有限。
  • 结果异质性高且证据确定性中等,相关结论需谨慎采纳并需进一步研究。

研究设计与样本

  • 系统文献综述与Meta分析,共纳入16项研究、1360名受试者。
  • 采用ROBINS-I工具评估偏倚风险,采用Cochrane GRADE方法评估证据确定性。
  • 根据方法学异质性采用随机效应或固定效应模型合并均数差和比值比。

关键影像表现/征象

  • MRCP中菠萝汁对比检查的胆管可见度高于平扫,胰管可见度也提高。
  • 食物类对比剂在MRE中优质图像获取可能性低于合成对比剂。

诊断标准与关键数值

  • 菠萝汁MRCP与非对比MRCP相比,胆管可见度合并均数差为1.04(95% CI: 0.23, 1.84;I2=96%,p<0.01)。
  • 菠萝汁MRCP与非对比MRCP相比,胰管可见度合并均数差为0.95(95% CI: 0.04, 1.85;I2=95%,p<0.01)。
  • 与非对比MRCP相比,菠萝汁MRCP改善胰胆管可见度的合并比值比为5.01(95% CI: 2.34, 10.64;p<0.0001)。
  • 与合成对比剂相比,食物类对比剂获得优质MRE图像的比值比为0.36(95% CI: 0.18, 0.73;p=0.004)。
  • 所有结局的证据确定性均为中等。

临床应用与阅片要点

  • 可考虑将口服菠萝汁作为MRCP低成本阴性对比剂,但需注意其增强效果证据为中等确定性。
  • MRE中食物类对比剂优质图像率不如合成对比剂,报告时应警惕图像质量下降可能影响诊断。
  • 使用食物类对比剂前需关注不同研究间异质性较大,机构间方案和判读标准可能影响效果。

局限性

  • 纳入研究结果异质性高。
  • 证据确定性仅为中等。
  • 原始研究存在方法学偏倚风险,需进一步研究验证食物类对比剂在MRI及其他影像技术中的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the contrast enhancement potential of food-based substances (FBS) as clinical imaging agents in MR cholangiopancreatography (MRCP) and digestive tract investigations.

METHODS: A systematic literature search was conducted using a pre-defined strategy and inclusion criteria to identify relevant articles. Two review authors independently screened and selected papers for inclusion, conducted risk of bias assessment using ROBINS-I (Risk of Bias In Non-randomised Studies of Interventions) tool and assessed certainty of evidence using the Cochrane's GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Areas of disagreement were resolved through consensus and the involvement of a third reviewer. The data obtained were meta-analysed using both random and fixed effects models with inverse variance methods, depending on the included studies' methodological heterogeneity, to estimate the pooled mean difference and odds ratio.

RESULTS: 16 studies (1360 participants) were included in this review. Eight studies each examined the effectiveness of FBS for contrast enhancement in MRCP and MRE, respectively. The pooled mean differences between MRCP with pineapple juice and non-contrast MRCP were 1.04 (95 % CI: 0.23, 1.84; I2 = 96 %, p < 0.01) for bile duct visibility and 0.95 (95 % CI: 0.04, 1.85; I2 = 95 %, p < 0.01) for pancreatic duct visibility. Compared to non-contrast MRCP, MRCP with pineapple juice showed improved pancreaticobiliary duct visibility (Combined odds ratio, 5.01; 95 % CI: 2.34, 10.64; p < 0.0001). However, when compared with synthetic contrast agents, there is a lower likelihood of obtaining excellent quality MRE images with food-based contrast agents (FBCAs) (odds ratio, 0.36; 95 % CI: 0.18, 0.73, 0.73; p = 0.004). A generally high safety and acceptance profile was reported across the included studies for FBCAs. The certainty of the evidence obtained was considered moderate across all outcomes.

CONCLUSION: Oral administration of pineapple juice improves the diagnostic quality of MRCP investigations, while the contrast enhancement potential of FBS is limited in MRE studies. The high heterogeneity of results and moderate certainty of the evidence, however, require a cautious admission of results. Therefore, further research is necessary to gain a comprehensive understanding of the reliability of FBS in these MRI investigations, as well as in other imaging modalities that are yet to be explored.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Dushimirimana, Iweka, Rickman, et al. Contrast enhancement potential of food-based imaging agents in cholangiopancreatography and digestive tract investigations using MRI: A systematic literature review and meta-analysis. Eur J Radiol. 2026. PMID: 41506168. doi:10.1016/j.ejrad.2025.112633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。